160 related articles for article (PubMed ID: 23991296)
1. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.
Aksu F; Capan N; Aksu K; Ofluoğlu R; Canbakan S; Yavuz B; Akin KO
J Thorac Dis; 2013 Aug; 5(4):414-21. PubMed ID: 23991296
[TBL] [Abstract][Full Text] [Related]
2. Association of High Sensitive CRP Level and COPD Assessment Test Scores with Clinically Important Predictive Outcomes in Stable COPD Patients.
Ghobadi H; Fouladi N; Beukaghazadeh K; Ansarin K
Tanaffos; 2015; 14(1):34-41. PubMed ID: 26221150
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.
de Torres JP; Cordoba-Lanus E; López-Aguilar C; Muros de Fuentes M; Montejo de Garcini A; Aguirre-Jaime A; Celli BR; Casanova C
Eur Respir J; 2006 May; 27(5):902-7. PubMed ID: 16455829
[TBL] [Abstract][Full Text] [Related]
4. The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease.
Agarwal R; Zaheer MS; Ahmad Z; Akhtar J
Multidiscip Respir Med; 2013 Sep; 8(1):63. PubMed ID: 24073993
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
Olloquequi J; Jaime S; Parra V; Cornejo-Córdova E; Valdivia G; Agustí À; Silva O R
Respir Res; 2018 Jan; 19(1):13. PubMed ID: 29347936
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
7. Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension.
Yang D; Wang L; Jiang P; Kang R; Xie Y
J Healthc Eng; 2022; 2022():3247807. PubMed ID: 35186226
[TBL] [Abstract][Full Text] [Related]
8. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
9. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.
Liu SF; Wang CC; Chin CH; Chen YC; Lin MC
Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335
[TBL] [Abstract][Full Text] [Related]
10. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
12. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD.
Khan NA; Daga MK; Ahmad I; Mawari G; Kumar S; Kumar N; Husain SA
J Inflamm Res; 2016; 9():187-198. PubMed ID: 27920567
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
15. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
[TBL] [Abstract][Full Text] [Related]
16. Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification.
Lin YH; Wang WY; Hu SX; Shi YH
Pak J Med Sci; 2016; 32(6):1453-1458. PubMed ID: 28083044
[TBL] [Abstract][Full Text] [Related]
17. Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients.
Sarioglu N; Alpaydin AO; Coskun AS; Celik P; Ozyurt BC; Yorgancioglu A
Multidiscip Respir Med; 2010 Apr; 5(2):84-91. PubMed ID: 22958780
[TBL] [Abstract][Full Text] [Related]
18. Epicardial fat thickness is associated with severity of disease in patients with chronic obstructive pulmonary disease.
Kiraz K; Gökdeniz T; Kalaycıoglu E; Börekçi A; Akyol S; Baykan AO; Acele A; Karakoyun S; Seker T; Gür M
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4508-4515. PubMed ID: 27874948
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
[TBL] [Abstract][Full Text] [Related]
20. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
